Cel Sci Corporation (CVM)

[jamesnhansen]

CTE Answer for Biobonic's 47% OS from Literature

Biobonic...

VERY interesting. I've prepared a new calculator for you using the 47% 3 1/2 year survival data "extracted from literature" in Cel-Sci's P2 study.

Using those assumptions, the OAS is inferred to be 107% improvement.

Here's the interesting thing about these date and guesses for the dropout rate and the CTE:

You can't change it much without the trial ending too quickly, so the inputs are constrained. Goof with it yourself.

I've read the P2 study again today. It occurs to me that combining Multikine with Avastin might make sense. The immune system attacks the tumor and the Avastin turns off the food supply (angiogenesis).

Cheers from a gray day in Oregon,

Jim